Absolute lymphocyte count (ALC) ? 500/mm3
Absolute lymphocyte count (ALC) <400/µL.
Absolute lymphocyte count (ALC) >500/µL
Adequate organ function within 14 days of study registration including:\r\n* Absolute lymphocyte count (ALC) >= 0.5 x 10^9/L
Absolute lymphocyte count (ALC) >= 500/ mm^3
Absolute lymphocyte count (ALC) >= 100 cells/ul
PART I: Absolute lymphocyte count (ALC) >= 300 cells/mm^3
PART II: ALC >= 500 cells/mm^3
Absolute lymphocyte count (ALC) of > 5,000 K/uL
Absolute lymphocyte count (ALC) ? 300/mm^3, and absolute number of CD3+ T cells > 150/mm^3
Absolute blood lymphocyte (ALC) >= 100 cells/ul\r\n* If subject has an apheresis product or T cells available for manufacturing of T cell product, there is no minimum ALC requirement
Absolute blood lymphocyte (ALC) >= 100 cells/ul\r\n* If subject has an apheresis product or T cells available for manufacturing of T cell product, there is no minimum ALC requirement
Absolute lymphocyte count (ALC) >= 0.8 x 10^9/L.
Absolute lymphocyte count (ALC) >1000 cells/mm3
Absolute lymphocyte count (ALC) >= 500/mm^3
Patient must have no persistent toxicities from prior therapy >= grade 2 with the exception of\r\nhematologic indices (i.e., hemoglobin, white blood cell count [WBC], ANC, absolute lymphocyte count [ALC])
Absolute lymphocyte count (ALC) >= 500/uL
Absolute lymphocyte count (ALC) >= 100 cells/ul
Absolute lymphocyte count (ALC) > 500
Patients must have absolute lymphocyte counts (ALC) of more than 5,000 cell/mm^3
Absolute lymphocyte count (ALC) > 800/ul
Absolute lymphocyte count (ALC) >= 500/mm^3
Absolute lymphocyte count (ALC) >= 800/uL
Absolute lymphocyte count (ALC) ? 300/mm3
Progressive lymphocytosis in the absence of infection, with an increase in blood Absolute Lymphocyte Count (ALC) >=50% over a 2-month period, or a lymphocyte doubling time (LDT) of <6 months (as long as initial ALC was >=30000/µl).
either ALC >10 000/µL, or
Absolute lymphocyte count (ALC) ? 1 × 10e3/µL
Patients with a diagnosis of CLL (any stage) with absolute lymphocyte count (ALC) >= 20 x 109/l, requiring therapy
Absolute lymphocyte count (ALC) >= 250/uL obtained =< 7 days prior to registration
For Phase 1b individuals: absolute lymphocyte count (ALC) > 5000/?L in peripheral blood.
Absolute lymphocyte count (ALC) >= 0.5 X 10^9/L
Absolute lymphocyte count (ALC) >= 200/?L
ALC >100/uL
Absolute lymphocyte count (ALC) ? 1,000/?l (? 500/?l after stem cell transplant) Note: After completion of dose escalation, patients with AML are not required to meet these hematologic criteria.
